MDL nieuws
- Technology to optimize liver disease care with AI─powered algorithms, imaging analysis & predictive modelling
- [Obituary] Nancy Elinor Adler
- Efficacy of pharmacologic interventions on magnetic resonance imaging biomarkers in patients with nonalcoholic fatty liver disease: systematic review and network meta?analysis
- Risk stratification of synchronous gastric cancers including alcohol?related genetic polymorphisms
- Nika Pharma buys technologies for three drugs in tablet form and one dietary supplement
- Let’s unite Hepatology! Become an EASL member today and discover your benefits
- From the Editor’s Desk...
- A different picture on liver biopsy
- Global incidence and prevalence of gastritis and duodenitis from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
- Clinical and patient?reported outcomes in patients with chronic hepatitis B and C and non?alcoholic fatty liver disease from real?world practices in Saudi Arabia, Turkey and Egypt
- Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbab le, gut-restricted adsorbent in models and patients with cirrhosis
- FDA grants ODD to Candel Therapeutics’ pancreatic cancer treatment
- The contribution of small heterodimer partner to the occurrence and progression of cholestatic liver injury
- Elevation of S2?bound ?1?acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma
- Safety and efficacy of endoscopic ultrasound?guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta?analysis